One of the postdocs just raised an issue I've never seriously considered. Many surface structures on bacterial cells undergo what's called "phase variation". That is, a key gene controlling the structure has evolved to have a high rate of mutations that switch it from an active allele to an inactive allele, and from the inactive allele to an active one.
By "high frequency" here I mean more often than one switch per million cell divisions. Switching is thus still a very rare event, but is much higher than the background mutation rate for normal DNA sequences. Such elevated frequencies are usually caused either by short sequence repeats that cause DNA polymerase to add or miss bases in critical positions, or by specific DNA-altering enzymes that recognize the gene.
That's the proximate cause of the variation. The ultimate cause (the evolutionary cause) is thought to be natural selection created by predators or host immune systems that recognize the surface structure and attack cells expressing it. Under such pressure, a cell that has turned the structure off will have an advantage, so cells with elevated mutation rates affecting the structure are favoured. Because the structure is strongly advantageous in the absence of external attack, selection favours cells that also have a high rate of reversion mutations that switch the structure back on. Such genes are often called "contingency loci".
Competence for DNA uptake requires expressing DNA uptake proteins on the cell surface, so it's a logical target for attack by the host immune system, and thus perhaps for phase variation. But how would we detect it? In Neisseria competence is known to be phase variable, but only because it depends on the phase-variable expression of type 4 pili, a phenotype that is easily assayed in the lab. Screening H. influenzae cells for phase variation of competence is likely to be very difficult, as our only assays are uptake of radioactive DNA and transformation to antibiotic resistance.
Rather than screening for variation, a more efficient approach is to examine the H. influenzae genome for sequences that could promote such variation, and check each for its ability to affect competence. These have been thoroughly investigated by Richard Moxon and his colleagues. They found no enzymatic switches but many short sequence repeats affecting production of complex carbohydrates on the cell surface. Now we need to carefully check whether any of these could also affect genes needed for DNA uptake.
- Home
- Angry by Choice
- Catalogue of Organisms
- Chinleana
- Doc Madhattan
- Games with Words
- Genomics, Medicine, and Pseudoscience
- History of Geology
- Moss Plants and More
- Pleiotropy
- Plektix
- RRResearch
- Skeptic Wonder
- The Culture of Chemistry
- The Curious Wavefunction
- The Phytophactor
- The View from a Microbiologist
- Variety of Life
Field of Science
-
-
Change of address1 year ago in Variety of Life
-
Change of address1 year ago in Catalogue of Organisms
-
-
Earth Day: Pogo and our responsibility1 year ago in Doc Madhattan
-
What I Read 20241 year ago in Angry by Choice
-
I've moved to Substack. Come join me there.1 year ago in Genomics, Medicine, and Pseudoscience
-
-
-
-
Histological Evidence of Trauma in Dicynodont Tusks7 years ago in Chinleana
-
Posted: July 21, 2018 at 03:03PM8 years ago in Field Notes
-
Why doesn't all the GTA get taken up?8 years ago in RRResearch
-
-
Harnessing innate immunity to cure HIV10 years ago in Rule of 6ix
-
-
-
-
-
-
post doc job opportunity on ribosome biochemistry!11 years ago in Protein Evolution and Other Musings
-
Blogging Microbes- Communicating Microbiology to Netizens11 years ago in Memoirs of a Defective Brain
-
Re-Blog: June Was 6th Warmest Globally12 years ago in The View from a Microbiologist
-
-
-
The Lure of the Obscure? Guest Post by Frank Stahl14 years ago in Sex, Genes & Evolution
-
-
Lab Rat Moving House15 years ago in Life of a Lab Rat
-
Goodbye FoS, thanks for all the laughs15 years ago in Disease Prone
-
-
Slideshow of NASA's Stardust-NExT Mission Comet Tempel 1 Flyby15 years ago in The Large Picture Blog
-
in The Biology Files
Not your typical science blog, but an 'open science' research blog. Watch me fumbling my way towards understanding how and why bacteria take up DNA, and getting distracted by other cool questions.
Showing posts with label competence. Show all posts
Showing posts with label competence. Show all posts
Sxy continued
7. The reduced competence caused by the compensatory mutations in the sxy-6 strain proves that the sxy-1 and sxy-3 mutations cause hypercompetence by decreasing the number of base pairs in folded sxy mRNA. To confirm the effect, and to see how strongly the folding can inhibit sxy expression, we made a mutant with two extra base pairs (sxy-7). As predicted, it is even less competent - in fact it can't be transformed at all (Fig. 6A).
8. The sxy-6 mutant isn't just not hypercompetent, it's much less competent than wildtype cells (10-fold to 500-fold, depending on the assay conditions), even though it is predicted to have the same number of base pairs when folded. This was especially surprising because its mutations replace a strong G:C basepair with a weaker A:T basepair. This may be telling us that in wildtype mRNA the G and C bases interact with bases at other positions as well as with each other, and that these unknown interactions enhance expression of sxy.
9. We also directly checked the amounts of Sxy protein in the sxy-6 and sxy-7 mutants; it's much less than in the parent mutants and in wildtype cells (Fig. 6B). I don't have the draft version of Fig. 6B yet, although the data has been collected.
10. We don't know how the mRNA base pairing prevents sxy expression, although we are considering several possibilities, all involving effects either on the amount of sxy mRNA in the cell, or on the ability of the mRNA to be translated into protein. To distinguish between these, we examined the amounts of sxy mRNA in wildtype and mutant cells under various culture conditions. If folding reduces Sxy protein by reducing the amount of mRNA, then the mutant cells should have amounts of sxy mRNA proportional to their amounts of Sxy protein. If folding acts only by preventing translation, then the mutants should all have the same amount of sxy mRNA as wildtype cells.
The results are intermediate. The mutants contain less sxy mRNA than the wildtype cells, but they contain more mRNA than we would expect from their reduction in Sxy protein (Fig. 7; I don't have all of the final data for this figure). This means that the folding must limit both the amount of sxy mRNA and its ability to be translated into protein.
11. This conclusion is supported by data from gene fusions that put the E. coli lacZ gene under control of sxy mRNA. One kind of fusion ("operon fusion") tells us about effects of sxy amount and on folding on mRNA amount; the other ("protein fusion") tells us about the combined effects on mRNAmRNA translatability. [I hope I've got this right - I find it very hard to keep these effects straight.] We (i.e. a former PhD student) constructed two pairs of fusions. In one pair, both fusions (protein and operon) join lacZ gene (to a downstream position in the wildtype sxycodon 89), meaning that in both the mRNA can fold normally. In the other pair, both fusions join lacZ to a position further upstream (codon 11) in the mRNA, bypassing a part of the mRNA essential for folding (so these fusion RNAs should have no folding).
It will be nice if the direct measurements of mRNA and Sxy protein (by real-time PCR and immunoblot respectively; Fig. 7) give the same magnitude of effects as the fusions. The preliminary data for Fig. 7 suggests a stronger effect of translatability than the fusions suggest.
13. Work by another group about 10 years ago had suggested that sxy transcription is stimulated by cAMP, and they reported that the sxy promoter contained a CRP binding site responsible for this effect. We find that adding cAMP reduces expression of the sxy operon fusion. This is consistent with the location of a CRP site in a position where it will block transcription rather than stimulating it. I don't think this result deserves a figure (maybe because we don't have pretty data).
14. We did some microarray analysis of expression of all genes in the sxy-1 hypercompetent mutant, under conditions that don't induce competence in wildtype cells. We can mention that all the competence regulon (CRP-S regulon) genes were being overexpressed. We won't show the data as we haven't done lots of microarray replicates (maybe we only did one). This should probably be described briefly under point 2 in the previous post.
15. We have examined the predicted foldings of sxy mRNAs from related species in the family Pasteurellaceae. None of them were predicted to fold like H. influenzae sxy. This could just be mentioned in the Discussion.
8. The sxy-6 mutant isn't just not hypercompetent, it's much less competent than wildtype cells (10-fold to 500-fold, depending on the assay conditions), even though it is predicted to have the same number of base pairs when folded. This was especially surprising because its mutations replace a strong G:C basepair with a weaker A:T basepair. This may be telling us that in wildtype mRNA the G and C bases interact with bases at other positions as well as with each other, and that these unknown interactions enhance expression of sxy.
9. We also directly checked the amounts of Sxy protein in the sxy-6 and sxy-7 mutants; it's much less than in the parent mutants and in wildtype cells (Fig. 6B). I don't have the draft version of Fig. 6B yet, although the data has been collected.
10. We don't know how the mRNA base pairing prevents sxy expression, although we are considering several possibilities, all involving effects either on the amount of sxy mRNA in the cell, or on the ability of the mRNA to be translated into protein. To distinguish between these, we examined the amounts of sxy mRNA in wildtype and mutant cells under various culture conditions. If folding reduces Sxy protein by reducing the amount of mRNA, then the mutant cells should have amounts of sxy mRNA proportional to their amounts of Sxy protein. If folding acts only by preventing translation, then the mutants should all have the same amount of sxy mRNA as wildtype cells.
The results are intermediate. The mutants contain less sxy mRNA than the wildtype cells, but they contain more mRNA than we would expect from their reduction in Sxy protein (Fig. 7; I don't have all of the final data for this figure). This means that the folding must limit both the amount of sxy mRNA and its ability to be translated into protein.
11. This conclusion is supported by data from gene fusions that put the E. coli lacZ gene under control of sxy mRNA. One kind of fusion ("operon fusion") tells us about effects of sxy amount and on folding on mRNA amount; the other ("protein fusion") tells us about the combined effects on mRNAmRNA translatability. [I hope I've got this right - I find it very hard to keep these effects straight.] We (i.e. a former PhD student) constructed two pairs of fusions. In one pair, both fusions (protein and operon) join lacZ gene (to a downstream position in the wildtype sxycodon 89), meaning that in both the mRNA can fold normally. In the other pair, both fusions join lacZ to a position further upstream (codon 11) in the mRNA, bypassing a part of the mRNA essential for folding (so these fusion RNAs should have no folding).
Caveat: I don't know whether we've checked the predicted folding of the codon 11 fusion mRNAs. It will lack the base pairings involved in the mutations we've studied (the main stem), but could still have the other 'internal' base pairs that we think might block access to the translation start site.After much tearing of hair and drawing on the whiteboard, I think it's clearest to consider the no-folding fusions first, and then examine how folding changes lacZ expression (measured as beta-galactosidase activity). The no-folding protein fusion produces 2.8 times as much beta-galactosidase as the no-folding operon fusion. We expect both to have the same amount of mRNA, so this means that the sxy translational signals (ribosome-binding site and start codon) work 2.8 times better than the lacZones. That's neither surprising nor interesting in this context. The folding operon fusion produces only 0.45 as much activity as the corresponding no-folding fusion, telling us that folding reduces the amount of mRNA to 0.45. The folding protein fusion produces only 0.20 as much activity as the comparable no-folding fusion. We expect the folding fusion to have produced 0.45 as much mRNA, so the folded mRNA must be translated only 0.44 as well as the no-folding mRNA (Fig. 8).
It will be nice if the direct measurements of mRNA and Sxy protein (by real-time PCR and immunoblot respectively; Fig. 7) give the same magnitude of effects as the fusions. The preliminary data for Fig. 7 suggests a stronger effect of translatability than the fusions suggest.
13. Work by another group about 10 years ago had suggested that sxy transcription is stimulated by cAMP, and they reported that the sxy promoter contained a CRP binding site responsible for this effect. We find that adding cAMP reduces expression of the sxy operon fusion. This is consistent with the location of a CRP site in a position where it will block transcription rather than stimulating it. I don't think this result deserves a figure (maybe because we don't have pretty data).
14. We did some microarray analysis of expression of all genes in the sxy-1 hypercompetent mutant, under conditions that don't induce competence in wildtype cells. We can mention that all the competence regulon (CRP-S regulon) genes were being overexpressed. We won't show the data as we haven't done lots of microarray replicates (maybe we only did one). This should probably be described briefly under point 2 in the previous post.
15. We have examined the predicted foldings of sxy mRNAs from related species in the family Pasteurellaceae. None of them were predicted to fold like H. influenzae sxy. This could just be mentioned in the Discussion.
Subscribe to:
Posts (Atom)